Compare UTHR & ZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTHR | ZM |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 26.8B |
| IPO Year | 1999 | 2019 |
| Metric | UTHR | ZM |
|---|---|---|
| Price | $566.91 | $100.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 22 |
| Target Price | ★ $567.57 | $94.14 |
| AVG Volume (30 Days) | 357.4K | ★ 4.3M |
| Earning Date | 05-06-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.07 | ★ 92.52 |
| EPS | 5.82 | ★ 6.18 |
| Revenue | $1,483,300,000.00 | ★ $4,868,769,000.00 |
| Revenue This Year | $6.39 | $7.30 |
| Revenue Next Year | $14.18 | $3.96 |
| P/E Ratio | $98.73 | ★ $15.86 |
| Revenue Growth | 2.38 | ★ 4.36 |
| 52 Week Low | $272.18 | $69.15 |
| 52 Week High | $609.35 | $111.56 |
| Indicator | UTHR | ZM |
|---|---|---|
| Relative Strength Index (RSI) | 49.02 | 55.90 |
| Support Level | $560.68 | $79.55 |
| Resistance Level | $603.63 | N/A |
| Average True Range (ATR) | 15.81 | 4.26 |
| MACD | -1.77 | -0.80 |
| Stochastic Oscillator | 13.86 | 47.70 |
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.
Zoom Communications provides a video-first communications platform that connects people through frictionless video, voice, chat, and content sharing. The company's cloud-native platform enables video experiences and connects users across various devices and locations in a single meeting. Zoom has launched a variety of communications-related solutions, including Zoom Phone and Zoom Contact Center. The firm was founded in 2011 and serves companies of all sizes from all industries around the world.